entertainment -WSS

entertainment

author：fashion 2025-09-30 14:34:28 - browse：134

Hyacinth Empinado/STAT

The body mass index, or BMI, is the formula that’s used most often to diagnose overweight and obesity. But unlike other common diagnoses, there is a certain stigma applied to people with a high body mass index, or BMI, which can affect how they are perceived by peers, providers, and society at large.

Despite the ubiquity of the BMI in medicine, many argue that it is a flawed tool, with a strange history. In recent months, the BMI has become more relevant than ever as the new semaglutide weight loss drugs are poised to change how obesity is understood and treated.

BMI is a simple calculation — a person’s weight in kilograms divided by the square of their height. But how BMI is then translated into a diagnosis is complicated and flawed.

Related: New weight loss drugs are changing the narrative on obesity, with a push from pharma

Watch this video to learn more about the history of the BMI — how it became so entrenched in medicine and, surprisingly, how its introduction may have set back decades of work on how obesity contributes to disease.

A STAT series is examining new obesity drugs that are transforming patients’ lives, dividing medical experts, and spurring one of the biggest business battles in years. Read more about The Obesity Revolution.

Previous article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
Next article： Doctors push to include dialysis machines in emergency stockpile

WSS

Tuberculosis patients need more than just free medication

Kansas bar where gunfire wounded 9 last month closes permanently

Truvian presents data for its desktop blood

Democrats are overperforming in 2023's special elections. Is it a clue for Biden vs. Trump?

NFL doctors' conflicts of interest could endanger players, report says

NFL doctors' conflicts of interest could endanger players, report says

explore

entertainment

Related: New weight loss drugs are changing the narrative on obesity, with a push from pharma

hotspot

As demand for Covid shots wanes, Moderna seeks its next success

Sage considers ways to reduce costs following FDA rejection

Trump demands the U.S. pay no more for drugs than other countries … again

Many breast cancer patients receive more radiation than needed

Tori Bowie and the unacceptable rates of Black maternal death

Trump used to be more articulate. What could explain the change?

Medical leaders decry Supreme Court decision on affirmative action

NFL doctors' conflicts of interest could endanger players, report says

Supreme Court strikes down use of affirmative action

St. Louis police protesters begin picking up checks in $4.9 million settlement

explore

Slovenia has suffered its worst

Biogen says it will cut costs by $700 million, slash 1,000 jobs

What to watch for from Zogenix and Amicus clinical trials

Flash flood warnings continue for parts of Missouri, Illinois

Mexico finds 491 migrants being held at vacant lot, almost all are from Guatemala

Roche’s Alnylam deal shows drug firms interested in heart drugs

focus

hotspot

focus

knowledge